Work

A phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707) (1308)

Year: 2023

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2023.06.211

Authors: Matthew Block, Eleftheria Kalogera, Vera Suman, Wendy Nevala, Darragh O'Donoghue, Jill Schimke, Carrie Strand, Gretchen Glaser, Megan Grudem, Aminah Jatoi, Carolyn Klampe, Amanika Kumar, Carrie Langstraat, Andrea Wahner Hendrickson, Saravut Weroha, Joel Reid, Svetomir Markovic

Institutions: Mayo Clinic, Baptist Health South Florida

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4386948003

FWCI: 0.056

Cites:

Cited by: 1

Related to: 10